about
Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disordersMore than just dancing: experiences of people with Parkinson's disease in a therapeutic dance program.Parkinson's disease or Parkinson symptoms following seasonal influenza.Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?Deep brain stimulation in Parkinson's diseaseSurface effects mediate self-assembly of amyloid-β peptides.Economic evaluation of occupational therapy in Parkinson's disease: A randomized controlled trial.The effects of mental practice in neurological rehabilitation; a systematic review and meta-analysis.Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectivesParkinson Symptoms and Health Related Quality of Life as Predictors of Costs: A Longitudinal Observational Study with Linear Mixed Model AnalysisReformulating psychological difficulties in people with Parkinson's disease: the potential of a social relational approach to disablism.Abnormalities of regional brain function in Parkinson's disease: a meta-analysis of resting state functional magnetic resonance imaging studies.Family Functioning and Communication in Spouses of Patients with Parkinsonism.Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.Early versus delayed initiation of pharmacotherapy in Parkinson's disease.A review of presented mathematical models in Parkinson's disease: black- and gray-box models.Proteomic studies associated with Parkinson's disease.Dicer and microRNAs protect adult dopamine neurons.Acute Hospital Admissions of Individuals with a Known Parkinson's Disease Diagnosis in Ireland 2009-2012: A Short Report.Perceptions of people living with Parkinson's disease: a qualitative study in Iran.Biophysical Characterization of α-Synuclein and Rotenone Interaction.The health-related, social, and economic consequences of parkinsonism: a controlled national study.Average annual cost of Parkinson's disease in São Paulo, Brazil, with a focus on disease-related motor symptoms.Patient and caregiver perceptions of the social impact of advanced Parkinson's disease and dyskinesias.Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in C. elegans Models of Parkinson's Disease.Quality of life related to swallowing in Parkinson's disease.Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.The cost-effectiveness of levodopa/carbidopa intestinal gel compared to standard care in advanced Parkinson's disease.Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.An evaluation of the patient education programme for Parkinson's disease in clinical practice.Implementation of a multidisciplinary psychoeducational intervention for Parkinson's disease patients and carers in the community: study protocol.Experience of care home residents with Parkinson's disease: Reason for admission and service use
P2860
Q28302151-C12B1CAD-B2CA-4B02-ADAA-46DA681C22BEQ30388429-40845F83-4A8E-4F44-B816-D1AEFB3E105FQ30403795-4E4C2B7F-68A8-43A7-9412-C33456B3F466Q33785397-FF7058E6-32E9-4A64-86F0-6A9FF4B8FD8EQ34255809-8E2B78C7-6BE9-41CE-B3E2-402624ABE2FBQ34419863-6D8450E1-F336-477D-A59F-370AF9CE5D5EQ34470840-0D0CAA18-8020-40B3-AD2F-74C5FCECDD4CQ34917324-C02390A7-90AB-45E9-BDDE-344953ADB997Q35187475-D981C103-C3DC-4A46-A149-1649E460426FQ35876969-D3EAA399-F970-45DB-A7F9-576C813D0FC9Q37127123-C4640B63-6BEE-4D54-995F-D04393E725DFQ37581547-68C98DAD-5CB8-4E76-9E71-868F5C3E481CQ37639121-5DB1E2BD-98C6-4BEE-BF87-0FEFF80BA6A8Q37809870-1C9BF967-9CFF-4ADC-A291-DD756380CB40Q38039857-02572346-F115-4A57-AF3D-D2382C4DF848Q38206403-1023C13F-B9BE-426D-9730-564736058C6FQ38627411-F80121B6-6E3F-49A0-923E-8722645B42B5Q38761409-472823A0-1B1F-43D9-8E36-618F3FEF5965Q38765041-AB8FD66E-CCB2-4E10-8152-D43A7A1B1337Q39357719-36295970-6214-4077-81F7-A5B132CCC758Q39695818-1558F7C7-1E24-4B71-B8E4-AEC5250142ACQ39871699-BA740641-487E-4F7B-9C1A-F82E9AD65DF9Q43608397-993793A5-52A2-46D2-A420-8BA306206B97Q47098412-000B9621-E674-44DF-8DBC-0916EA842CB0Q47215658-5D6AAEEA-F89F-48E1-A0BA-5FB8335DF9CDQ47655102-A08E971E-2CA4-497D-A29C-4293B7D07FC6Q47858424-18785A35-E815-4AED-B0C0-6B3FF56B3ACDQ47868277-A8C838AD-962A-4DE4-BECA-EAE9AF16034FQ47997995-53891AF7-2E66-45A6-90DC-8F9541CB12C9Q48184416-D3E113CF-508D-4A45-98E9-C464EB50911BQ50607888-34F08E13-5595-4C75-86D6-EA7209D99DFEQ54994684-140A0CFF-E575-4731-BD93-6B91516EB408Q59296656-20886AFC-B799-45CE-B827-1542B95859F4
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The economic impact of Parkinson's disease
@ast
The economic impact of Parkinson's disease
@en
The economic impact of Parkinson's disease
@en-gb
The economic impact of Parkinson's disease
@nl
type
label
The economic impact of Parkinson's disease
@ast
The economic impact of Parkinson's disease
@en
The economic impact of Parkinson's disease
@en-gb
The economic impact of Parkinson's disease
@nl
prefLabel
The economic impact of Parkinson's disease
@ast
The economic impact of Parkinson's disease
@en
The economic impact of Parkinson's disease
@en-gb
The economic impact of Parkinson's disease
@nl
P1476
The economic impact of Parkinson's disease
@en
P2093
Leslie J. Findley
P304
P356
10.1016/J.PARKRELDIS.2007.06.003
P407
P577
2007-09-01T00:00:00Z